Skip to main content

Table 2 Adverse events included in the PRO-CTCAE for melanoma patients receiving immunotherapy based on findings in medical records, literature review and product information

From: Selection of patient reported outcomes questions reflecting symptoms for patients with metastatic melanoma receiving immunotherapy

Frequency of Adverse Events

CTCAE terms

Literature review

Medical records

Product information

PRO-CTCAE symptom terms

Very common (may affect more than 1 in 10 people)

Vomiting

X

 

x

Vomiting

Nausea

x

x

x

Nausea

Anorexia

x

x

x

Decreased appetite

Diarrhea

x

x

x

Diarrhea/Loose or watery stool

Abdominal pain

x

x

x

Abdominal pain

Constipation

x

 

x

Constipation

Rash

x

x

x

Rash

Pruritus

x

x

x

Itching

Dyspnea

x

  

Shortness of breath

Myalgia

x

x

 

Muscle pain

Arthralgia

x

x

x

Joint pain

Fatigue

x

x

x

Fatigue

Injection site reaction

  

x

Pain and swelling at injection site

Headache

x

x

 

Headache

Chills

x

x

 

Chills

̽Asthenia

x

 

x

 

Common (may effect up to 1 in 10 people

Mucositis (oral)

x

x

x

Mouth/throat sores

Dry skin

x

x

x

Skin dryness

Alopecia

x

 

x

Hair loss

Blurred vision

x

x

x

Blurred vision

Cough

x

x

x

Cough

Dysgeusia

x

x

x

Taste changes

Dizziness

x

x

x

Dizziness

Edema

x

 

x

Swelling

Pain

x

 

x

General pain

Peripheral sensory neuropathy

 

x

x

Numbness & tingling

Hot Flashes

x

 

x

Hot flashes

̽Flu –like symptoms

 

x

x

 

̽Pain in extremity

x

 

x

 

̽Back pain

x

 

x

 

Uncommon/not present

Depression (2 items)

 

x

 

Discouraged Sad

Blood in stool